Register Today Menu

"On the other hand, we denounce with righteous indignation and dislike men who are so beguiled and demoralized by the charms of pleasure of the moment, so blinded by desire, that they cannot foresee the pain and trouble that are bound to ensue; and equal blame belongs to those who fail in their duty through weakness of will, which is the same as saying through shrinking from toil and pain. These cases are perfectly simple and easy to distinguish. In a free hour, when our power of choice is untrammelled and when nothing prevents our being able to do what we like best, every pleasure is to be welcomed and every pain avoided. But in certain circumstances and owing to the claims of duty or the obligations of business it will frequently occur that pleasures have to be repudiated and annoyances accepted. The wise man therefore always holds in these matters to this principle of selection: he rejects pleasures to secure other greater pleasures, or else he endures pains to avoid worse pains."

"At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat."

Simbec-Orion Clinical Pharmacology will soon be running a two part study to investigate a drug called MB272.

The overall objectives of the study are to determine the safety, tolerability and concentration in the blood of the study drug when evaluated in different conditions i.e., different dose strengths, following administration of single and multiple doses, and following administration in two different forms.

The study also aims to evaluate the effect of the study drug on the body, through the collection of blood samples at different times through the day.

Simbec-Orion Clinical Pharmacology will soon be running a two part study to investigate a drug called MB272.

The overall objectives of the study are to determine the safety, tolerability and concentration in the blood of the study drug when evaluated in different conditions i.e., different dose strengths, following administration of single and multiple doses, and following administration in two different forms.

The study also aims to evaluate the effect of the study drug on the body, through the collection of blood samples at different times through the day.

Simbec-Orion Clinical Pharmacology will soon be running a two part study to investigate a drug called MB272.

The overall objectives of the study are to determine the safety, tolerability and concentration in the blood of the study drug when evaluated in different conditions i.e., different dose strengths, following administration of single and multiple doses, and following administration in two different forms.

The study also aims to evaluate the effect of the study drug on the body, through the collection of blood samples at different times through the day.

"Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?"

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum."

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

"On the other hand, we denounce with righteous indignation and dislike men who are so beguiled and demoralized by the charms of pleasure of the moment, so blinded by desire, that they cannot foresee the pain and trouble that are bound to ensue; and equal blame belongs to those who fail in their duty through weakness of will, which is the same as saying through shrinking from toil and pain. These cases are perfectly simple and easy to distinguish. In a free hour, when our power of choice is untrammelled and when nothing prevents our being able to do what we like best, every pleasure is to be welcomed and every pain avoided. But in certain circumstances and owing to the claims of duty or the obligations of business it will frequently occur that pleasures have to be repudiated and annoyances accepted. The wise man therefore always holds in these matters to this principle of selection: he rejects pleasures to secure other greater pleasures, or else he endures pains to avoid worse pains."

Posts list

If you are a healthy female aged between 18 and 55, then you may be eligible to participate in a study investigating a new drug being developed for the treatment of a condition called Multiple Sclerosis (MS). 

Study Payment* £7,950.

Apply for this study

*Terms & Conditions apply.

Study Payment: £7,950

"*" indicates required fields

Step 1 of 3

33%

This field is hidden when viewing the form

Advertising Source

* indicates a required field

By agreeing to this form and selecting the box as outlined below, you are confirming that you have read the information provided in our data protection and consent policy, and give your consent for Simbec-Orion to record and retain your personal and special categories of data for the purposes and duration(s) stated in our policy linked above.

Please confirm that you have read these terms and understand that Simbec-Orion will be holding and processing your personal and special categories of data for the purposes stated in our policy linked above.

Simbec-Orion are also required to process your bio-metric data (a photograph only when you attend an onsite screening visit), we do this to ensure we can identify you for security purposes. We do not share this data with any other third-party, we solely use this data for the purpose of recognition. For the completion of your enrolment and part of your eligibility, we are required to collect this data. By selecting the box below, you also explicitly consent to the use of your bio-metric data as and when it is collected.

Agreement*

I understand and wish to proceed

* indicates a required field

Have you used any of the following forms of contraception within the following restriction windows?*

Which of the following best describes you or your contraceptive status?Oral contraceptives or oral hormone therapies within the past 30 daysImplanted hormonal contraceptives within the past 6 monthsInjectable contraceptives within the past 12 monthsHormonal coils or topical hormonal contraceptives e.g., creams, patches, gels or films within the past 3 monthsNone of the above

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Are you currently using one of the following forms of contraception and have been using this for at least 14 days?*

Which of the following best describes you or your contraceptive status?Non-hormonal Intrauterine device (IUD)Bilateral tubal occlusionHysterectomyVasectomised partnerSexual abstinence (refraining from heterosexual intercourse as the preferred and usual lifestyle choice)None of the above

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Are you registered with a GP*

Yes

No

(must be a UK resident for at least 1 year)?

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to register at this time.

You need to be registered with a GP for at least 3 months in order to participate in a clinical trial. This is to ensure your safety, and your past medical history can be safely evaluated from your GP to assess your suitability for each and every trial.

Have you been diagnosed or tested positive for Coronavirus/COVID-19 within the last month?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you received a COVID-19 vaccine or any other type of vaccine within the last 4 weeks?*

Yes

No

If yes, please give details of vaccine, including the date

Do you suffer from or ever had any serious illnesses as diagnosed by your GP or health professional?*

Yes

No

(e.g., neurological, endocrinal, cardiovascular, pulmonary, haematological, immunologic, psychiatric, gastrointestinal, renal, hepatic and metabolic disease)

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Do you suffer from/have a history of gastro-intestinal conditions or surgeries within the last 12 weeks?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Are you taking any prescription or repeat medication from a GP or a chemist*

Yes

No

(including inhalers, over-the-counter medications, and vitamins or supplements)

If yes, please give details*

Do you regularly use illegal drugs?*

Yes

No

(i.e., Substances that are used for non-medicinal and leisure purposes. We test as part of the screening procedures.)

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply at this time.

Have you completed any other studies in the last 30 days?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you ever suffered from a serious allergic reaction or have a known severe allergy?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Do you smoke or use any nicotine products (including vapes and eCigarettes)?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you smoked or used any nicotine products within the last 6 months?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you donated blood in the last 3 months?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you donated plasma in the last 2 weeks?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you donated platelets in the last 6 weeks?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Do you drink alcohol?*

Yes

No

Do you consume more than 14 units per week?*

Yes

No

(For example, a can of beer/cider/lager is approximately 2 units)

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Have you had any body piercings or tattoos in the last 3 months?*

Yes

No

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

* indicates a required field

Your details

First Name*

Last Name*

Sex Assigned at Birth*

Please select your gender at birthMaleFemale

Date of Birth*

DayDay12345678910111213141516171819202122232425262728293031

MonthMonth123456789101112

YearYear202720262025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980197919781977197619751974197319721971197019691968196719661965196419631962196119601959195819571956195519541953195219511950194919481947194619451944194319421941194019391938193719361935193419331932193119301929192819271926192519241923192219211920

This field is hidden when viewing the form

Age

Height*

Please select your height below4 foot 8 (142cm)4 foot 9 (145cm)4 foot 10 (147cm)4 foot 11 (150cm)5 foot (152cm)5 foot 1 (155cm)5 foot 2 (157cm)5 foot 3 (160cm)5 foot 4 (163cm)5 foot 5 (165cm)5 foot 6 (168cm)5 foot 7 (170cm)5 foot 8 (173cm)5 foot 9 (175cm)5 foot 10 (178cm)5 foot 11 (180cm)6 foot (183cm)6 foot 1 (185cm)6 foot 2 (188cm)6 foot 3 (191cm)6 foot 4 (193cm)6 foot 5 (196cm)6 foot 6 (198cm)6 foot 7 (201cm)6 foot 8 (203cm)6 foot 9 (206cm)6 foot 10 (208cm)6 foot 11 (211cm)7 foot (213cm)

Weight*

Please select your weight below7 stone, 12 lb / 49.90 kg7 stone, 13 lb / 50.35 kg8 stone, 0 lb / 50.80 kg8 stone, 1 lb / 51.26 kg8 stone, 2 lb / 51.71 kg8 stone, 3 lb / 52.16 kg8 stone, 4 lb / 52.62 kg8 stone, 5 lb / 53.07 kg8 stone, 6 lb / 53.52 kg8 stone, 7 lb / 53.98 kg8 stone, 8 lb / 54.43 kg8 stone, 9 lb / 54.88 kg8 stone, 10 lb / 55.34 kg8 stone, 11 lb / 55.79 kg8 stone, 12 lb / 56.25 kg8 stone, 13 lb / 56.70 kg9 stone, 0 lb / 57.15 kg9 stone, 1 lb / 57.61 kg9 stone, 2 lb / 58.06 kg9 stone, 3 lb / 58.51 kg9 stone, 4 lb / 58.97 kg9 stone, 5 lb / 59.42 kg9 stone, 6 lb / 59.87 kg9 stone, 7 lb / 60.33 kg9 stone, 8 lb / 60.78 kg9 stone, 9 lb / 61.23 kg9 stone, 10 lb / 61.69 kg9 stone, 11 lb / 62.14 kg9 stone, 12 lb / 62.60 kg9 stone, 13 lb / 63.05 kg10 stone, 0 lb / 63.50 kg10 stone, 1 lb / 63.96 kg10 stone, 2 lb / 64.41 kg10 stone, 3 lb / 64.86 kg10 stone, 4 lb / 65.32 kg10 stone, 5 lb / 65.77 kg10 stone, 6 lb / 66.22 kg10 stone, 7 lb / 66.68 kg10 stone, 8 lb / 67.13 kg10 stone, 9 lb / 67.59 kg10 stone, 10 lb / 68.04 kg10 stone, 11 lb / 68.49 kg10 stone, 12 lb / 68.95 kg10 stone, 13 lb / 69.40 kg11 stone, 0 lb / 69.85 kg11 stone, 1 lb / 70.31 kg11 stone, 2 lb / 70.76 kg11 stone, 3 lb / 71.21 kg11 stone, 4 lb / 71.67 kg11 stone, 5 lb / 72.12 kg11 stone, 6 lb / 72.57 kg11 stone, 7 lb / 73.03 kg11 stone, 8 lb / 73.48 kg11 stone, 9 lb / 73.94 kg11 stone, 10 lb / 74.39 kg11 stone, 11 lb / 74.84 kg11 stone, 12 lb / 75.30 kg11 stone, 13 lb / 75.75 kg12 stone, 0 lb / 76.20 kg12 stone, 1 lb / 76.66 kg12 stone, 2 lb / 77.11 kg12 stone, 3 lb / 77.56 kg12 stone, 4 lb / 78.02 kg12 stone, 5 lb / 78.47 kg12 stone, 6 lb / 78.93 kg12 stone, 7 lb / 79.38 kg12 stone, 8 lb / 79.83 kg12 stone, 9 lb / 80.29 kg12 stone, 10 lb / 80.74 kg12 stone, 11 lb / 81.19 kg12 stone, 12 lb / 81.65 kg12 stone, 13 lb / 82.10 kg13 stone, 0 lb / 82.55 kg13 stone, 1 lb / 83.01 kg13 stone, 2 lb / 83.46 kg13 stone, 3 lb / 83.91 kg13 stone, 4 lb / 84.37 kg13 stone, 5 lb / 84.82 kg13 stone, 6 lb / 85.28 kg13 stone, 7 lb / 85.73 kg13 stone, 8 lb / 86.18 kg13 stone, 9 lb / 86.64 kg13 stone, 10 lb / 87.09 kg13 stone, 11 lb / 87.54 kg13 stone, 12 lb / 88.00 kg13 stone, 13 lb / 88.45 kg14 stone, 0 lb / 88.90 kg14 stone, 1 lb / 89.36 kg14 stone, 2 lb / 89.81 kg14 stone, 3 lb / 90.26 kg14 stone, 4 lb / 90.72 kg14 stone, 5 lb / 91.17 kg14 stone, 6 lb / 91.63 kg14 stone, 7 lb / 92.08 kg14 stone, 8 lb / 92.53 kg14 stone, 9 lb / 92.99 kg14 stone, 10 lb / 93.44 kg14 stone, 11 lb / 93.89 kg14 stone, 12 lb / 94.35 kg14 stone, 13 lb / 94.80 kg15 stone, 0 lb / 95.25 kg15 stone, 1 lb / 95.71 kg15 stone, 2 lb / 96.16 kg15 stone, 3 lb / 96.62 kg15 stone, 4 lb / 97.07 kg15 stone, 5 lb / 97.52 kg15 stone, 6 lb / 97.98 kg15 stone, 7 lb / 98.43 kg15 stone, 8 lb / 98.88 kg15 stone, 9 lb / 99.34 kg15 stone, 10 lb / 99.79 kg15 stone, 11 lb / 100.24 kg15 stone, 12 lb / 100.70 kg15 stone, 13 lb / 101.15 kg16 stone, 0 lb / 101.60 kg16 stone, 1 lb / 102.06 kg16 stone, 2 lb / 102.51 kg16 stone, 3 lb / 102.97 kg16 stone, 4 lb / 103.42 kg16 stone, 5 lb / 103.87 kg16 stone, 6 lb / 104.33 kg16 stone, 7 lb / 104.77 kg16 stone, 8 lb / 105.23 kg16 stone, 9 lb / 105.68 kg16 stone, 10 lb / 106.14 kg16 stone, 11 lb / 106.59 kg16 stone, 12 lb / 107.04 kg16 stone, 13 lb / 107.5 kg17 stone, 0 lb / 107.95 kg17 stone, 1 lb / 108.4 kg17 stone, 2 lb / 108.86 kg17 stone, 3 lb / 109.31 kg17 stone, 4 lb / 109.76 kg17 stone, 5 lb / 110.22 kg17 stone, 6 lb / 110.67 kg17 stone, 7 lb / 111.13 kg17 stone, 8 lb / 111.58 kg17 stone, 9 lb / 112.03 kg17 stone, 10 lb / 112.49 kg17 stone, 11 lb / 112.94 kg17 stone, 12 lb / 113.39 kg17 stone, 13 lb / 113.85 kg18 stone, 0 lb / 114.3 kg18 stone, 1 lb / 114.75 kg18 stone, 2 lb / 115.21 kg18 stone, 3 lb / 115.66 kg18 stone, 4 lb / 116.11 kg18 stone, 5 lb / 116.57 kg18 stone, 6 lb / 117.02 kg18 stone, 7 lb / 117.48 kg18 stone, 8 lb / 117.93 kg18 stone, 9 lb / 118.38 kg18 stone, 10 lb / 118.84 kg18 stone, 11 lb / 119.29 kg18 stone, 12 lb / 119.74 kg18 stone, 13 lb / 120.2 kg19 stone, 0 lb / 120.65 kg19 stone, 1 lb / 121.1 kg19 stone, 2 lb / 121.56 kg19 stone, 3 lb / 122.01 kg19 stone, 4 lb / 122.46 kg

Your BMI

Your BMI

This field is hidden when viewing the form

BMI Calc

Thank you for your time and interest, but unfortunately based on your answer, you are not eligible to apply for this study.

Please register with our database as we may have studies in the near future which you may be eligible, register here This way we can be in contact as soon as you are eligible for another trial.

Race*

Please select your race belowAmerican Indian or Alaska NativeAsianBlack or African AmericanNative Hawaiian or Other Pacific IslanderWhiteUnknownOther Race (please state below)

Your Race*

Street Address*

City*

Postcode*

Phone Number*

Email*

Can we contact you by email?

Yes

Can we contact you by SMS?

Yes

Can we contact you by phone?

Yes

Please select at least one contact mechanism to facilitate your participation in future clinical studies.

Study Information

Simbec-Orion Clinical Pharmacology will soon be running a study to investigate a new study drug being developed as a potential treatment for a condition known as Multiple Sclerosis (MS), which is a neurological condition in which the body’s immune system mistakenly attacks the protective lining surrounding nerve cells in the brain and spinal cord causing damage and inflammation.

The main objectives of the study are as follows: 

• To investigate if there are any interactions between the study drug and a combined oral contraceptive (the pill) and to evaluate if these interactions impact the levels of the study drug or the pill in the blood. 

• To investigate the safety of the study drug, and any side effects which may be associated with the study drug when it is given as multiple doses for up to 14 days.

If you participate in this study, you will be required to stay at the Simbec-Orion clinical unit for a maximum period of 22 days (21 overnight stays) and complete a post study follow-up visit on Day 30 (a minimum of 10 days following the last dose of study drug). Therefore, you should ensure that you are able to commit to completing all visits before agreeing to participate in this study.

Ready? Let’s get started

Purpose and Timeline

This study is classed as a drug-drug interaction study and will consist of up to 22 healthy female participants. This means that participants will be given a drug (combined oral contraceptive pill) which has known effects and a known method of breakdown in the body and also given the study drug to determine if there is any interaction between the drugs in the body and whether administration of the study drug affects the safety, tolerability and levels of the pill in the blood.

On Days 5-16, participants will take once daily doses of the study drug before taking a single dose of both the study drug and combined oral contraceptive pill together on Day 17 with the final dose of the study drug to be administered on Day 18. Each participant will receive the study drug and the combined oral contraceptive pill in the form of coated tablets which participants will swallow with water.

Stay Requirements

The treatment period for this study will require participants to stay overnight at the clinical unit for 21 overnight stays (from admission Day -1 to discharge Day 21). The treatment period is split into two parts and participants will remain in the clinical unit for the duration of both parts (1 and 2) of the treatment period.

Visits

Screening visit

Admission for the study is on Day -1 of Treatment Period Part 1. Discharge on day 21.

Post Study Follow-up Visit to be completed on Day 30.

Study Payment

If you complete this study, you will receive a maximum inconvenience payment of £7950.

Plus travel expenses.

Screening Visit
Day -35 to Day -2

Treatment Period Part 1

Day -1 to Day 5

Treatment Period Part 2

Day 5 to Day 21

Post Study Follow-up Visit

Day 30

Apply Now. Be Amazing

1914 translation by H. Rackham

06/12/2023

“On the other hand, we denounce with righteous indignation and dislike men who are so beguiled and demoralized by the charms of pleasure of the moment, so blinded by desire, that they cannot foresee the pain and trouble that are bound to ensue; and equal blame belongs to those who fail in their duty through […]

Read

Section 1.10.33 of “de Finibus Bonorum et Malorum”, written by Cicero in 45 BC

06/12/2023

“At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, […]

Read

News item from Simbec-Orion

06/12/2023

Simbec-Orion Clinical Pharmacology will soon be running a two part study to investigate a drug called MB272. The overall objectives of the study are to determine the safety, tolerability and concentration in the blood of the study drug when evaluated in different conditions i.e., different dose strengths, following administration of single and multiple doses, and […]

Read

Section 1.10.32 of “de Finibus Bonorum et Malorum”, written by Cicero in 45 BC

06/12/2023

“Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque […]

Read

The standard Lorem Ipsum passage, used since the 1500s

06/12/2023

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat […]

Read

What is Lorem Ipsum?

05/12/2023

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into […]

Read